SERPINF1 and neoplasm: There were no significant differences between the patients with LPTC and high-risk PTMC in gender, age distribution, multifocal tumors, extrathyroidal invasion, Hashimoto's disease, lymph node metastasis, tumor TNM stages, PEDF positive expression, and rate of recurrent disease.